they are going into many different industries. Also, automobile manufacturers are now using rearview and surround view cameras. OmniVision has gained significant market share with OEM's in Europe and the U.S. Going forward, this can be a strategic win and help the company increase its market share in the automotive camera market.
OmniVision holds 23% market share in this segment as per the company's data and growing car sale All major smartphone manufacturers will be vying for a major share of market. This would be a great place for R& D and cash. Security and different industries will make up for any weakness going foreword, I would think. This stock goes up and down a lot. You can play this one. OmniVision will also be able to profit in the security market. Technologies with streaming to phones and devices, high quality imaging, and video alerts/alarms are in demand. AUTOS - There are 24 applications, just an automobile that Omni Vision can profit from. Cars can have over 5 cameras plus sensors. As inventive new applications emerge and the Smartphone and tablet markets mature, the company is looking for alternative revenues in image sensors.
China mobile means 20% more business for Apple . Some has been priced in , but the suppliers could be the back door to Apple once again.
Now at Lion, one of Singh's top priorities is to take its product, TILs (tumor-infiltrating lymphocytes), and combine it with anti-PD-1s. Already in a Phase 2 study on patients with the severest and most deadly form of melanoma, TILs produced a 22% complete response, and 19 of the 20 patients who achieved a complete response are still alive 6-9 years later. In a study of 136 patients treated at NCI, MD Anderson and other top institutions, TILs produced a 50% objective response, which is far better than any other FDA approved late-stage melanoma treatment, a second and third line salvage setting where all other treatments had failed.
They have split the business for quite a while, The front facing is OVTI and the back Sony. The models vary as well as digital device and model. The shorts are scaring people and trying to get out of their position realizing business has been picking up any way.... The company famously lost the main camera spot in Apple's (NASDAQ: AAPL ) iPhones back in 2011, replaced by BSI chips from Sony (NYSE: SNE ) . OmniVision does sell chips to Apple today, but these are normally the skimpier and less profitable front-facing cameras. Then again, Apple's share of the global mobility space isn't as beefy as it once was, so it's easier to make up for a lost Apple socket with a couple of Android-based wins nowadays.
This is going to double ! OCLS just did and SQNM will be getting some good############# numbers &&&&&&&&&&&&& news soon. SAN DIEGO, Calif. and ST. OUEN L'AUMONE, France, Dec. 4, 2013 /PRNewswire/ -- Sequenom, Inc. (SQNM), a life sciences company providing innovative testing and genetic analysis solutions, announced that Laboratoire Cerba has launched its validated noninvasive prenatal test (NIPT) to health care providers and their patients in France, Belgium, Luxembourg and portions of the Middle East and Africa. Laboratoire Cerba's test utilizes patented technology licensed from Sequenom to analyze the relative amounts of chromosomes 21, 18 and 13 in cell-free fetal DNA obtained from a maternal blood sample.
This from a NVDA guy that don't want to compare charts for the last 5 days.......or year?????????? .....AMD up 8% for the last five days and up 75% for the year.... WHY is NVDA flat for the year and last 5 days?????????? ..... Mhhhhh the guys have to come here to vent their dead money.
NVDA clowns think the only games have to be ran on a PC now. Super gaming machines.......... DYING
The stock will double... It has the science and it works, We have had ongoing discussions regarding potential strategic partnership. Obtaining a partner or partners would allows us to leverage the partner’s exiting sales, marketing, distribution and manufacturing infrastructure while reducing the need to build up our own infrastructure. The stock is primed for news and has huge upside potential here.
they can try all they want but every body that knows any one with diabetes is buying.
$ 4.78 2,100 $ 4.80 419 $ 4.79 300 $ 4.79 100 $ 4.78 100 $ 4.78 100 $ 4.78 100 $ 4.78 100 16:33 $ 4.78 658 $ 4.75 100 $ 4.77 900 $ 4.75 400 $ 4.75 100 steady climb now